Literature DB >> 2193779

Valve site-specific pathogenetic differences between right-sided and left-sided bacterial endocarditis.

A S Bayer1, D C Norman.   

Abstract

Entities:  

Mesh:

Year:  1990        PMID: 2193779     DOI: 10.1378/chest.98.1.200

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  11 in total

1.  Identification of virulence genes in a pathogenic strain of Pseudomonas aeruginosa by representational difference analysis.

Authors:  Ji Young Choi; Costi D Sifri; Boyan C Goumnerov; Laurence G Rahme; Frederick M Ausubel; Stephen B Calderwood
Journal:  J Bacteriol       Date:  2002-02       Impact factor: 3.490

2.  Activities of daptomycin and vancomycin alone and in combination with rifampin and gentamicin against biofilm-forming methicillin-resistant Staphylococcus aureus isolates in an experimental model of endocarditis.

Authors:  Kerry L LaPlante; Suzanne Woodmansee
Journal:  Antimicrob Agents Chemother       Date:  2009-06-29       Impact factor: 5.191

3.  Treatment of experimental staphylococcal endocarditis due to a strain with reduced susceptibility in vitro to vancomycin: efficacy of ampicillin-sulbactam.

Authors:  M Backo; E Gaenger; A Burkart; Y L Chai; A S Bayer
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

4.  Activity of daptomycin or linezolid in combination with rifampin or gentamicin against biofilm-forming Enterococcus faecalis or E. faecium in an in vitro pharmacodynamic model using simulated endocardial vegetations and an in vivo survival assay using Galleria mellonella larvae.

Authors:  Megan K Luther; Marios Arvanitis; Eleftherios Mylonakis; Kerry L LaPlante
Journal:  Antimicrob Agents Chemother       Date:  2014-05-27       Impact factor: 5.191

5.  A rot mutation restores parental virulence to an agr-null Staphylococcus aureus strain in a rabbit model of endocarditis.

Authors:  Peter J McNamara; Arnold S Bayer
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

6.  Tricarboxylic acid cycle-dependent attenuation of Staphylococcus aureus in vivo virulence by selective inhibition of amino acid transport.

Authors:  Yefei Zhu; Yan Q Xiong; Marat R Sadykov; Paul D Fey; Mei G Lei; Chia Y Lee; Arnold S Bayer; Greg A Somerville
Journal:  Infect Immun       Date:  2009-08-10       Impact factor: 3.441

7.  Evidence of less severe aortic valve destruction after treatment of experimental staphylococcal endocarditis with vancomycin and dexamethasone.

Authors:  P Siaperas; A Pefanis; D Iliopoulos; I Katsarolis; A Kyroudi-Voulgari; I Donta; P Karayiannakos; H Giamarellou
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

8.  Role of mgrA and sarA in methicillin-resistant Staphylococcus aureus autolysis and resistance to cell wall-active antibiotics.

Authors:  María Pilar Trotonda; Yan Q Xiong; Guido Memmi; Arnold S Bayer; Ambrose L Cheung
Journal:  J Infect Dis       Date:  2009-01-15       Impact factor: 5.226

9.  Infective Endocarditis in Intravenous Drug Abusers.

Authors:  José M. Miró; Asuncion Moreno; Carlos A. Mestres
Journal:  Curr Infect Dis Rep       Date:  2003-08       Impact factor: 3.725

10.  Efficacy of trovafloxacin, a new quinolone antibiotic, in experimental staphylococcal endocarditis due to oxacillin-resistant strains.

Authors:  A S Bayer; C Li; M Ing
Journal:  Antimicrob Agents Chemother       Date:  1998-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.